Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 267
7
Diseases
6
Unique genes
0.344
Avg. similarity score
Congenital aortic valve atresia
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital aortic valve atresia
Congenital mitral valve atresia
Intellectual developmental disorder language autism
Malt lymphoma
intellectual disability-severe speech delay-mild dysmorphism syndrome
Intellectual developmental disorder seizures hypotonia skeletal
combined immunodeficiency due to MALT1 deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital aortic valve atresia | 5 | 5 | 1 |
| Congenital mitral valve atresia | 5 | 5 | 1 |
| Intellectual developmental disorder language autism | 5 | 5 | 1 |
| Malt lymphoma | 5 | 5 | 5 |
| intellectual disability-severe speech delay-mild dysmorphism syndrome | 5 | 5 | 1 |
| Intellectual developmental disorder seizures hypotonia skeletal | 4 | 4 | 2 |
| combined immunodeficiency due to MALT1 deficiency | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FOXP1 | 6 / 7 | Congenital aortic valve atresia, Congenital mitral valve atresia, Intellectual developmental disorder language autism, Intellectual developmental disorder seizures hypotonia skeletal and 2 more |
| MALT1 | 2 / 7 | combined immunodeficiency due to MALT1 deficiency, Malt lymphoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| NF-kappa B signaling pathway | KEGG | 3 / 105 | 57.2× | 1.27e-5 | 4.11e-4 ✓ sig. |
| Activation of NF-kappaB in B cells | Reactome | 2 / 66 | 60.7× | 4.40e-4 | 7.21e-3 ✓ sig. |
| FCERI mediated NF-kB activation | Reactome | 2 / 79 | 50.7× | 6.30e-4 | 9.55e-3 ✓ sig. |
| CLEC7A (Dectin-1) signaling | Reactome | 2 / 79 | 50.7× | 6.30e-4 | 9.55e-3 ✓ sig. |
| B cell receptor signaling pathway | KEGG | 2 / 91 | 44.0× | 8.35e-4 | 1.18e-2 ✓ sig. |
| Downstream TCR signaling | Reactome | 2 / 98 | 40.9× | 9.68e-4 | 1.32e-2 ✓ sig. |
| C-type lectin receptor signaling pathway | KEGG | 2 / 105 | 38.1× | 1.11e-3 | 1.47e-2 ✓ sig. |
| T cell receptor signaling pathway | KEGG | 2 / 122 | 32.8× | 1.49e-3 | 1.84e-2 ✓ sig. |
| CLEC7A/inflammasome pathway | Reactome | 1 / 6 | 334× | 2.99e-3 | 3.07e-2 ✓ sig. |
| Tuberculosis | KEGG | 2 / 181 | 22.1× | 3.26e-3 | 3.26e-2 ✓ sig. |
| Attachment of GPI anchor to uPAR | Reactome | 1 / 7 | 286× | 3.49e-3 | 3.42e-2 ✓ sig. |
| Regulation of necroptotic cell death | Reactome | 1 / 11 | 182× | 5.48e-3 | 4.65e-2 ✓ sig. |
| Shigellosis | KEGG | 2 / 250 | 16.0× | 6.13e-3 | 5.01e-2 |
| RIPK1-mediated regulated necrosis | Reactome | 1 / 16 | 125× | 7.97e-3 | 5.96e-2 |
| Transcriptional regulation of pluripotent stem cells | Reactome | 1 / 17 | 118× | 8.46e-3 | 6.20e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to fungus | GO:0009620 | 2 / 6 | 1,038× | 1.29e-6 | 1.01e-4 ✓ sig. |
| positive regulation of protein ubiquitination | GO:0031398 | 3 / 78 | 120× | 1.39e-6 | 1.07e-4 ✓ sig. |
| regulation of T cell receptor signaling pathway | GO:0050856 | 2 / 8 | 779× | 2.40e-6 | 1.67e-4 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 3 / 232 | 40.3× | 3.68e-5 | 1.43e-3 ✓ sig. |
| non-canonical NF-kappaB signal transduction | GO:0038061 | 2 / 34 | 183× | 4.80e-5 | 1.74e-3 ✓ sig. |
| regulation of apoptotic process | GO:0042981 | 3 / 254 | 36.8× | 4.82e-5 | 1.74e-3 ✓ sig. |
| lipopolysaccharide-mediated signaling pathway | GO:0031663 | 2 / 38 | 164× | 6.01e-5 | 2.06e-3 ✓ sig. |
| positive regulation of T cell activation | GO:0050870 | 2 / 45 | 138× | 8.45e-5 | 2.67e-3 ✓ sig. |
| regulation of macrophage colony-stimulating factor production | GO:1901256 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| positive regulation of immune effector process | GO:0002699 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| regulation of inflammatory response | GO:0050727 | 2 / 106 | 58.8× | 4.71e-4 | 9.20e-3 ✓ sig. |
| T cell receptor signaling pathway | GO:0050852 | 2 / 121 | 51.5× | 6.13e-4 | 1.10e-2 ✓ sig. |
| positive regulation of interleukin-21 production | GO:0032745 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| regulation of monocyte differentiation | GO:0045655 | 1 / 2 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |